|Title:||Extruded orally administrable opioid formulations|
|Abstract:||Bioavailable sustained release oral opioid analgesic dosage forms, comprising a plurality of multiparticulates produced via melt extrusion techniques are disclosed.|
|Inventor(s):||Oshlack; Benjamin (New York, NY), Chasin; Mark (Manalapan, NJ), Huang; Hua-Pin (Englewood Cliffs, NJ)|
|Assignee:||Euro-Celtique, S.A. (Luxembourg, LU)|
Patent Claim Types:|
see list of patent claims
|Composition; Formulation; Compound; Dosage form; Use;|
Field: Not categorized
Back Citations: 239th percentile
Forward Citations: 8th percentile
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.